knowledge -WSS

knowledge

author：hotspot 2025-09-30 15:15:20 - browse：79

A new treatment for Alzheimer’s disease developed by Eli Lilly slowed patients’ rate of cognitive and functional decline by 35% compared to placebo, the company said Wednesday, paving the way for a submission to the Food and Drug Administration and boosting hopes for a new class of Alzheimer’s drugs.

But the positive outcome of the study involving the drug, called donanemab, could be tempered by the deaths of two patients, and possibly a third, from a type of brain swelling caused by these drugs.

The results of the study were reported in a press release and have not yet been reviewed by outside scientists. Lilly said the data will be used to file for full approval with the FDA before the end of June. If cleared, donanemab will compete with another new Alzheimer’s treatment, Leqembi, made by Eisai and Biogen, that secured FDA approval in January.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Why failed clinical trials don’t always spell doom for a new drug

hotspot

WSS

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

A cyberattack has disrupted hospitals and health care in several states

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

White House drug shortage group privately met with industry

Nearly two

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

focus

knowledge

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

FDA panel issues narrow recommendation for Covid vaccine booster doses

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Stem cell clinics for heart failure: buyer be wary

Supreme Court strikes down use of affirmative action

Methadone doses haven’t kept up in the age of fentanyl

New air purifier tech could be key to improving indoor air quality

What Mike Pence has said that could be used in a Donald Trump trial

Novavax promises a turnaround & Lilly roils the obesity market

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Wikipedia

What Mike Pence has said that could be used in a Donald Trump trial

Attacks on the drug industry will lead to fewer breakthroughs

Police still searching for prisoner who escaped from NYC hospital

How to use technology to prevent future drug shortages

Friends ask where James Watson's attitudes about race came from

How to use technology to prevent future drug shortages

focus

hotspot

explore

hotspot